The global Pharmacogenomics Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenomics Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics Services. This report contains market size and forecasts of Pharmacogenomics Services in global, including the following market information:
- Global Pharmacogenomics Services Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genotyping Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics Services include Abbott Laboratories, Admera Health, LLC, Mesa Laboratories, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd., GeneOmbio Technologies Pvt Ltd., Exact Sciences Corporation, Illumina, Inc. and Laboratory Corporation of America Holdings, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Pharmacogenomics Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Services Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Pharmacogenomics Services Market Segment Percentages, by Type, 2022 (%)
- Genotyping
- SNP Identification
- Pharmacogenetic Testing
- Others
Global Pharmacogenomics Services Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Pharmacogenomics Services Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Infectious Diseases
- Psychiatry
- Cardiovascular
- Others
Global Pharmacogenomics Services Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Pharmacogenomics Services Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pharmacogenomics Services revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Pharmacogenomics Services revenues share in global market, 2022 (%)
key players include:
- Abbott Laboratories
- Admera Health, LLC
- Mesa Laboratories, Inc.
- Dynamic DNA Laboratories
- F. Hoffmann-La Roche Ltd.
- GeneOmbio Technologies Pvt Ltd.
- Exact Sciences Corporation
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- OmeCare
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- Precipio
- 23andMe, Inc.
- OneOme, LLC
- DiaCarta, Inc.
- OPKO Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmacogenomics Services, market overview.
Chapter 2: Global Pharmacogenomics Services market size in revenue.
Chapter 3: Detailed analysis of Pharmacogenomics Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacogenomics Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
